We are live on
!
Find out more
TAM
TFG Asset Management Portfolio holdings
AUM
$509M
1-Year Est. Return
24.47%
This Fund
S&P 500
This Quarter
Est. Return
-16.4%
1 Year Est. Return
+24.47%
3 Year Est. Return
+54.92%
5 Year Est. Return
+65.34%
10 Year Est. Return
+105.07%
AUM
$509M
AUM Growth
+$34.6M
(+7.3%)
Cap. Flow
+$147M
Cap. Flow
% of AUM
28.93%
Top 10 Holdings %
Top 10 Hldgs %
83.02%
Holding
38
New
10
Increased
15
Reduced
5
Closed
4
Top Buys
| 1 |
UiPath
PATH
|
+$98.8M |
| 2 |
Warner Bros
WBD
|
+$25.9M |
| 3 |
Workiva
WK
|
+$6.97M |
| 4 |
SLNO
Soleno Therapeutics
SLNO
|
+$4M |
| 5 |
Acadia Pharmaceuticals
ACAD
|
+$3.46M |
Top Sells
| 1 |
RAPT
RAPT Therapeutics
RAPT
|
+$4.46M |
| 2 |
Annexon
ANNX
|
+$4.17M |
| 3 |
FOLD
Amicus Therapeutics
FOLD
|
+$3.71M |
| 4 |
Praxis Precision Medicines
PRAX
|
+$2.17M |
| 5 |
Zevra Therapeutics
ZVRA
|
+$1.72M |
Sector Composition
| 1 | Technology | 63.41% |
| 2 | Healthcare | 24.23% |
| 3 | Energy | 7.37% |
| 4 | Communication Services | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
UiPath
PATH
$6.19B
| $280M | 54.98% |
25,207,628
+7,757,628
| +44% | +$98.8M |
|
|
KGEI
2
Kolibri Global Energy
KGEI
$182M
| $37.5M | 7.37% |
6,834,504
-100,000
| -1% | -$422K |
|
|
3
Warner Bros
WBD
$68.4B
| $25.4M | 4.98% |
+923,725
| New | +$25.9M |
|
|
4
Workiva
WK
$3.05B
| $14.9M | 2.93% |
250,000
+100,000
| +67% | +$6.97M |
|
5
Lyft
LYFT
$6.16B
| $13.3M | 2.61% |
1,000,000
| – | – |
|
6
Sprinklr
CXM
$1.35B
| $13.2M | 2.59% |
2,200,000
| – | – |
|
|
AUTL
7
Autolus Therapeutics
AUTL
$402M
| $13.1M | 2.58% |
9,500,000
| – | – |
|
8
Celldex Therapeutics
CLDX
$3.01B
| $9.91M | 1.95% |
312,316
+68,516
| +28% | +$1.87M |
|
9
Arrowhead Research
ARWR
$10.1B
| $7.98M | 1.57% |
127,198
+30,263
| +31% | +$1.92M |
|
10
Nektar Therapeutics
NKTR
$2.31B
| $7.41M | 1.46% |
103,037
+33,750
| +49% | +$1.92M |
|
|
11
Annexon
ANNX
$1.06B
| $7.16M | 1.41% |
1,292,455
-740,000
| -36% | -$4.17M |
|
12
Pharvaris
PHVS
$2.46B
| $6.26M | 1.23% |
221,611
+26,999
| +14% | +$721K |
|
13
Alkermes
ALKS
$8.66B
| $5.65M | 1.11% |
159,791
+18,619
| +13% | +$578K |
|
14
Agios Pharmaceuticals
AGIO
$2.37B
| $5.58M | 1.1% |
164,839
+2,821
| +2% | +$80K |
|
15
Immunovant
IMVT
$8.19B
| $5.43M | 1.07% |
218,507
+52,320
| +31% | +$1.35M |
|
|
16
Praxis Precision Medicines
PRAX
$8.88B
| $5.14M | 1.01% |
15,952
-7,000
| -30% | -$2.17M |
|
17
Krystal Biotech
KRYS
$10.3B
| $5.08M | 1% |
19,668
+7,854
| +66% | +$2.09M |
|
18
Dyne Therapeutics
DYN
$3.97B
| $4.68M | 0.92% |
258,132
+10,135
| +4% | +$175K |
|
19
Amylyx Pharmaceuticals
AMLX
$1.98B
| $4.42M | 0.87% |
317,877
+45,049
| +17% | +$634K |
|
|
MBX
20
MBX Biosciences
MBX
$2.89B
| $4.34M | 0.85% |
145,480
+2,153
| +2% | +$73.2K |
|
|
DFTX
21
Definium Therapeutics
DFTX
$6.06B
| $3.78M | 0.74% |
+199,994
| New | +$3.39M |
|
|
SLNO
22
DELISTED
Soleno Therapeutics
SLNO
| $3.42M | 0.67% |
+102,125
| New | +$4M |
|
23
Axsome Therapeutics
AXSM
$12.2B
| $3.39M | 0.67% |
20,059
-6,875
| -26% | -$1.19M |
|
24
Harmony Biosciences
HRMY
$2.02B
| $3.34M | 0.66% |
119,340
+36,516
| +44% | +$1.2M |
|
|
SLN
25
Silence Therapeutics
SLN
$494M
| $3.32M | 0.65% |
630,161
+264,792
| +72% | +$1.46M |
|
Similar funds
HNW
MCA
OA
PWMG
MC
WDG
B
OWP